Search
Eton Pharmaceuticals Inc
ETONAdd to Watchlist
56.460USD
+9.310+19.75%
Close 11-06 16:00（ET）
1.61BMarket Cap
LossP/E TTM
Eton Pharmaceuticals Inc (ETON) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Eton Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
71.500USD+37.03%
ETON Analyst Recommendation Trends
In the current month, ETON has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ETON average Analyst price target in the last month is 71.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
4
4
4
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
3
3
3
3
3
ETON Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, ETON EPS is projected to reach 0.365 in FY2026Q4, following reported EPS of 1.230 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.09
0.10
0.31
0.36
0.41
Actual
0.06
0.42
1.23
--
--
Surprise
-36.72%
+298.91%
+293.56%
--
--
FAQs
What is Eton Pharmaceuticals Inc's expected revenue for the next quarter?
Eton Pharmaceuticals Inc's expected revenue is 44.92M.
What is Eton Pharmaceuticals Inc's price target?
Analysts forecast that Eton Pharmaceuticals Inc's price target is USD 71.50, with the highest forecast at USD 78.00 and the lowest forecast at USD 68.00.
How have Eton Pharmaceuticals IncETON's recent earnings per share performed?
The market expectation was USD 1.23, while Eton Pharmaceuticals IncETON's earnings per share (EPS) for the previous quarter was USD 0.42. EPS for the next quarter is expected at USD 0.36.
What is the analyst rating for Eton Pharmaceuticals Inc?
Based on the ratings of Eton Pharmaceuticals Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.